In vitro activities of 15 oral beta-lactams against Klebsiella pneumoniae harboring new extended-spectrum beta-lactamases.
AUTOR(ES)
Kitzis, M D
RESUMO
The activities of 15 oral beta-lactams against Klebsiella pneumoniae harboring new extended-spectrum beta-lactamases were studied. All compounds were affected by these enzymes, especially by the SHV derivatives. Except for ceftibuten, the compounds with the greatest intrinsic activity were more affected by the presence of these enzymes than were older compounds with moderate intrinsic activity.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=171925Documentos Relacionados
- Extended-spectrum beta-lactamases.
- More extended-spectrum beta-lactamases.
- Aminoglycoside-modifying enzymes in clinical isolates harboring extended-spectrum beta-lactamases.
- Detection of Klebsiella pneumoniae and Escherichia coli strains producing extended-spectrum beta-lactamases.
- Activities of beta-lactam antibiotics against Escherichia coli strains producing extended-spectrum beta-lactamases.
